Change urged in analgesic prescriptions

Feb 28, 2007

The American Heart Association wants U.S. physicians to change the way they prescribe analgesics for patients with, or at risk for, heart disease.

The association said it based its recommendation on evidence that non-steroidal anti-inflammatory drugs, with the exception of aspirin, increase heart attack and stroke risks.

"We believe some physicians have been prescribing the new COX-2 inhibitors as the first line of treatment," said Dr. Elliott Antman, lead author of the association's statement and a professor at Harvard Medical School. "We are ... saying that, for chronic pain in patients with known heart disease or who are at risk for heart disease, these drugs should be the last line of treatment."

The AHA suggested physicians consider acetaminophen, aspirin and even short-term use of narcotic analgesics as the first step.

"If further relief is needed, physicians should suggest the least selective COX-2 inhibitors first, moving progressively toward more selective COX-2 inhibitors, which are at the bottom of the list, only if needed," the association said, noting all drugs should be used at the lowest dose necessary.

The full position statement appears in the journal Circulation.

Copyright 2007 by United Press International

Explore further: FDA OKs Cubist antibiotic for serious infections

add to favorites email to friend print save as pdf

Related Stories

A new century of Alzheimer's disease research

Jul 25, 2007

Imagine the day when a routine visit to the family doctor includes a simple blood test to predict the risk for developing Alzheimer’s disease (AD). If the test returns a worrisome result -- too many sticky brain proteins ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

10 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.